ESR1 and neoplasm: In 1992, we hypothesised that by inducing a G0-G1 state, anti-oestrogens in ER+, endocrine-dependent metastatic breast cancer counteracted tumour growth and the inhibition of the immune response promoted by oestrogen in the TME.